CXMT’s Fast-Track MSCI Entry Turns China’s DRAM Champion Into an Index Heavyweight

MSCI announced on July 28 that CXMT Corporation A would be added to both the standard and large-cap segments of the MSCI China All Shares Index, effective August 10. The benchmark covers large- and mid-cap Chinese companies across mainland A-shares, Hong Kong listings and foreign-listed Chinese equities. Analysts expected CXMT to become its second-largest constituent after Tencent, an extraordinary position for a company that had traded publicly for only two weeks. The speed was made possible by MSCI’s fast-track treatment of very large initial public offerings, rather than the normal quarterly review process. Funds designed to replicate the index must acquire CXMT shares in proportion to its assigned weight, while benchmark-aware active funds face pressure to evaluate the stock to avoid a significant tracking difference. The precise inflow cannot be determined without knowing the assets and inclusion factors applied by individual funds, and the China All Shares addition is not identical to inclusion in the better-known MSCI China or MSCI Emerging Markets indexes.

The market conditions surrounding CXMT’s listing make that distinction especially important. The company sold approximately 6.69 billion shares at 8.66 yuan each, raising 57.92 billion yuan, or about US$8.6 billion, in the largest mainland semiconductor offering on record. Proceeds could rise to 66.61 billion yuan if the over-allotment option is fully exercised. On its July 27 STAR Market debut, the stock closed at 49 yuan after briefly reaching 55.03 yuan, producing a first-day gain of almost 466 per cent and lifting the company’s market value to approximately 3.3 trillion yuan. Around 141.1 billion yuan of shares changed hands that day, the first time an A-share company had recorded more than 100 billion yuan in daily turnover. Yet only 6.73 per cent of the enlarged share capital was freely tradable at listing. Compulsory index buying against such a restricted float may support the price and improve liquidity, but it can also magnify volatility when short-term flows reverse.

CXMT’s operating growth provides a fundamental explanation for part of the excitement. Revenue reached 61.80 billion yuan in 2025, rising 155.6 per cent from the previous year. In the first quarter of 2026 alone, revenue increased 719.1 per cent year on year to 50.80 billion yuan, while net profit climbed to 33.01 billion yuan. Management expects first-half revenue of between 110 billion yuan and 120 billion yuan, almost twice the company’s full-year 2025 revenue, and net profit of 66 billion yuan to 75 billion yuan, reversing the loss recorded in the comparable period. CXMT was the world’s fourth-largest DRAM producer with an estimated 7.7 per cent market share in 2025, behind Samsung Electronics, SK Hynix and Micron. Its rapid expansion has coincided with a global memory shortage as leading manufacturers allocate more capacity to high-bandwidth memory and other premium products required by AI data centres, leaving conventional DRAM supplies tight.

Commercial adoption is also broadening. CXMT’s disclosed customers include Alibaba Cloud, ByteDance, Tencent, Lenovo, Xiaomi, Honor, Oppo, Vivo and Transsion, giving the company a substantial domestic market through which it can scale new products. A recent report said Apple was testing CXMT memory across devices including iPhones and MacBooks and had discussed using the components in products sold in China, although the report had not been independently confirmed by either company. HP and Acer have reportedly begun using CXMT chips in some devices sold outside the United States. These developments suggest that CXMT is moving beyond a protected domestic supplier role, although qualification by major international customers does not automatically mean it can compete at the technological frontier. The company remains behind the global leaders in high-bandwidth memory, where manufacturing yields, packaging and customer certification are particularly demanding.

CXMT’s investment case therefore combines industrial policy, an exceptional earnings cycle and considerable execution risk. State-owned shareholders controlled 36.29 per cent of the company before the IPO, with backers including Anhui government-related funds and China’s National Integrated Circuit Industry Investment Fund Phase II. The IPO capital is intended for production expansion, process upgrades, research and working capital, reinforcing Beijing’s goal of reducing dependence on foreign memory suppliers. At the same time, US export controls limit access to advanced manufacturing equipment, CXMT has been designated a Chinese military company by the US Department of Defense, and a possible addition to the US Entity List remains a material risk. The memory business is also highly cyclical: slower AI investment or aggressive capacity additions by competitors could quickly weaken prices and margins. MSCI inclusion confirms CXMT’s new importance in Chinese capital markets, but maintaining its ranking will require the company to prove that its earnings, technology and international customer base can develop as quickly as its valuation.